$ILMN

Meister Keith A. sold $14.4M of ILMN (indirect holdings)

Meister Keith A. sold 87,653 indirectly-held shares of ILLUMINA, INC. (ILMN) at $164.34 ($14.40M total) on 2026-06-01.

Original reporting
SEC EDGAR · Meister Keith A.
Published Jun 1, 2026, 10:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ILMN
Neutral
medium confidence
Mentioned
$ILMN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ILMNNeutralLow
01

Why it matters

The disclosure may slightly pressure sentiment around ILMN but is unlikely to change valuation absent accompanying operational news.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is not a standalone fundamental catalyst.

03

What to watch

Form 4s often aggregate routine transactions; without additional context (tax, diversification, prior plans), the signal may be overstated versus fundamentals.

Relevance 6/10Novelty 6/10Timing: Filed today (2026-06-01) for an open-market sale at $164.34/share

Background

SEC Form 4 reports insider transactions by directors/officers/10%+ holders; this one is an open-market sale by a director.

Company-level read

Ticker impact

$ILMNNeutralMedium confidence
Context

Illumina director Keith A. Meister sold 87,653 shares in an open-market transaction worth about $14.4M, disclosed via SEC Form 4.

Expected impact

Likely limited/short-lived impact; any move would be sentiment-driven rather than fundamentals.

Evidence & confidence

The filing is an ownership-change disclosure (not earnings/guidance/M&A). It does not indicate a company event, and the sale is not stated as part of a 10b5-1 plan, which can increase attention but still lacks a direct causal catalyst.

Market effects

Minor sentiment read-through for biotech/life-science tools; no direct sector catalyst from this single Form 4.

None specific; US-listed issuer disclosure only.

None specific; transaction is company-internal ownership activity.

Counterpoint

A director sale can reflect diversification or liquidity needs; absence of a stated 10b5-1 plan does not prove bearish intent.

Key entities

  • Illumina, Inc.

    US-listed life-science tools company whose director sold shares via SEC Form 4.

  • Keith A. Meister

    Director who executed the open-market sale disclosed in the filing.

Related articles

$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Illumina (ILMN) reported Q2 2026 revenue of $1.16B, up 9.5% YoY, and non-GAAP EPS of $1.31. Clinical consumables and NovaSeq X placements drove results. Gross margin was 68.2%. Full-year 2026 guidance was raised to $4.60B-$4.64B revenue and $5.30-$5.40 EPS. Cash was $1.17B vs $1.99B debt.

$ILMNHighAI 9/10

Illumina (ILMN) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Conor McNamara Chief Executive Officer - Jacob Thaysen Chief Financial Officer - Ankur Dhingra TAKEAWAYS Total Revenue -- $1.16 billion, representing a 9.5% increase year over year driven by clinical market demand and the NovaSeq X expansion. Rest of World Organic Revenue -- Increased 8.1% year over year, exceeding the high end of management's previous guidance.

$ILMNMedAI 8/10

Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full

Genomics company Illumina (NASDAQ: ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.62 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.31 per share was 6.8% above analysts’ consensus estimates. Is now the time to buy Illumina? Find out by accessing our full research report, it’s free.

$ILMNHigh

ILLUMINA, INC. (ILMN): Results of Operations and Financial Condition

ILLUMINA, INC. (ILMN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226earningsrelease.htm EX-99.1 Document Investors: Conor McNamara +1.858.291.6421 ir@illumina.com Media: Christine Douglass pr@illumina.com Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 San Diego, July 30, 2026 /PRNewswire/ -- Illumina, Inc.